Posts Tagged ‘country’
-
Wednesday, January 11th, 2012 at 07:56 | Comments Off
Average Binge Drinker Knocks Back 8 Drinks At a TimeCategories: Wall Street Journal
Heavy boozers are imbibing more frequently and knocking back more alcohol per binge than previously thought, according to new government data that looked, for the first time, at the detailed habits of binge drinkers.
One in six U.S. adults reported binge drinking at least once in 2010, a slight increase from the previous year, according to a Centers for Disease Control and Prevention report released today. Binge drinking is defined as a one-occasion consumption of at least four drinks for women ..read more
-
Thursday, December 29th, 2011 at 01:04 | Comments Off
A.M. Vitals: Study Questions Genetic Test for PlavixCategories: Wall Street Journal
Questioning the Use of a Genetic Test: A review of previously published research appearing in the Journal of the American Medical Association suggests that a genetic test for patients taking the anti-clotting drug Plavix doesn’t identify people at greater risk for a heart attack or other cardiac event, the WSJ reports. The FDA, which declined to comment on the study, last year put a black box warning on Plavix, cautioning about reduced effectiveness of the drug in ..read more
-
Friday, December 23rd, 2011 at 04:25 | Comments Off
Science Retracts Paper on XMRV-Chronic Fatigue Syndrome LinkCategories: Wall Street Journal
The journal Science has now fully retracted a paper it published in 2009 that linked chronic fatigue syndrome to the retrovirus XMRV.
The editor-in-chief of the journal, Bruce Alberts, wrote that “multiple laboratories, including those of the original authors” have failed to duplicate the findings of the paper, which reported finding XMRV in a greater proportion of CFS patients than healthy controls. The study excited patients, who hoped the discovery would lead to possible treatments, and sparked public-health worries over possible ..read more
-
Friday, December 23rd, 2011 at 03:13 | Comments Off
J&J Recall Watch: About 12 Million Bottles of Motrin PulledCategories: Wall Street Journal
Johnson & Johnson said it recalled about 12 million bottles of Motrin brand painkillers because some pills may not dissolve quickly, delaying pain relief.
As Dow Jones Newswires reports, it’s not a consumer-level recall, so people aren’t being asked to get rid of or return unused products. There are no safety concerns with the pills, some of which were distributed in the U.S.
We’ve been keeping tabs on J&J’s string of recalls, which cost it about $900 million in sales in 2010. ..read more
-
Thursday, September 22nd, 2011 at 00:42 | Comments Off
Visualizing Antibiotic Resistance With a New Online ToolCategories: Wall Street Journal
The problem of antibiotic resistance tends to reach public consciousness in a scattershot manner — when ground turkey is recalled because it’s tainted with salmonella that can’t be treated by common drugs, for example. But it’s hard to get a comprehensive picture of the extent to which certain infections have become impervious to treatment.
Now, Extending the Cure, an antibiotic-resistance policy effort based at the Center for Disease Dynamics, Economics & Policy, has developed a web-based tool to illustrate the problem ..read more
-
Thursday, September 15th, 2011 at 22:45 | Comments Off
Applying Venture Philanthropy to Chronic Fatigue SyndromeCategories: Wall Street Journal
Venture philanthropy — the model used to accelerate research and drug development in diseases such as multiple myeloma and cystic fibrosis — is now being applied to a new arena: chronic fatigue syndrome.
Scott A. Carlson, executive director of the newly launched Chronic Fatigue Initiative, tells the Health Blog the Hutchins Family Foundation is providing “over $10 million” in funding for projects through 2014, with the possibility of more depending on the findings.
The initiative wants to fund projects that hunt for ..read more
-
Monday, August 22nd, 2011 at 23:11 | Comments Off
Screening Newborns for Congenital Heart DiseaseCategories: Wall Street Journal
Last September, an HHS advisory committee recommended that all newborns be screened for critical congenital heart disease — a leading cause of death in infants younger than one year of age. The head of HHS, Kathleen Sebelius, hasn’t yet adopted the recommendation, requesting input on how to actually implement screening.
Now a separate working group convened by the HHS advisory committee — with members including pediatric cardiologists, nurses, and public-health officials — has weighed in with its own suggestions for how ..read more
-
Wednesday, August 17th, 2011 at 04:30 | Comments Off
Women Still Using Pai You Guo Supplement Despite BanCategories: Wall Street Journal
In 2009 the FDA recalled an over-the-counter weight-loss supplement called Pai You Guo because it contained two drugs — sibutramine, the active ingredient in the now-defunct Abbott drug Meridia, and phenolphthalein, an ingredient removed from over-the-counter laxatives after it was pegged as a potential carcinogen.
Pai You Guo can significantly raise blood pressure and pulse rate and might harm patients with a history of heart problems, the FDA said.
Well, the banned supplement never went away, at least in one ..read more
-
Tuesday, August 16th, 2011 at 22:53 | Comments Off
For Cancer Patients, Help Navigating the MazeCategories: Wall Street Journal
Hospitals are offering a new service to cancer patients: navigators to help them steer through the often-overwhelming maze of decisions, doctor visits and treatments, today’s Informed Patient Column reports.
Researchers across the country have been studying patient navigator programs for several years in an attempt to determine how best they can help patients — and how exactly they should be designed and staffed. A new supplement to the journal Cancer is devoted to the issue.
The National Consortium of Breast Centers offers ..read more
-
Tuesday, August 16th, 2011 at 22:43 | Comments Off
A.M. Vitals: Judge Rules Pfizer’s 2019 Viagra Patent is ValidCategories: Wall Street Journal
Viagra Protection: A federal judge ruled yesterday that a Pfizer patent on the erectile-dysfunction treatment Viagra is valid and enforceable, protecting the blockbuster drug against generic competition until 2019, the WSJ reports. Teva Pharmaceutical had proposed a generic version of the drug, arguing that certain claims of that 2019 Pfizer patent were invalid, the paper says.
Cheap Screening: Hospitals are advertising inexpensive low-dose CT scans for current and former smokers on the heels of a government study that ..read more
